BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xiong J, Lai S, Zhang P, Li Q, Wei Y, Yang Y, Wang T, Liu L, Ma X, Chen D. Rebamipide plus proton pump inhibitor versus proton pump inhibitor alone in the treatment of endoscopic submucosal dissection-induced gastric ulcer: a meta-analysis of randomized controlled trials. Medicine (Baltimore). 2014;93:e64. [PMID: 25211045 DOI: 10.1097/MD.0000000000000064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 . Retraction. Rebamipide plus proton pump inhibitor versus proton pump inhibitor alone in treatment of endoscopic submucosal dissection-induced gastric ulcer: a meta-analysis of randomized controlled trials. Medicine (Baltimore) 2014;93:399. [PMID: 25546656 DOI: 10.1097/MD.0000000000000399] [Reference Citation Analysis]
2 Simanenkov VI, Tikhonov SV. Rebamipide: New opportunities of gastroenteroprotection. Ter arkh 2015;87:134. [DOI: 10.17116/terarkh20158712134-137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
3 Ding YZ, Liu F, Dan ZL. Efficacy of proton pump inhibitors plus rebamipide for endoscopic submucosal dissection-induced ulcers: A Meta-analysis of randomized controlled trials. Shijie Huaren Xiaohua Zazhi 2015; 23(16): 2629-2636 [DOI: 10.11569/wcjd.v23.i16.2629] [Reference Citation Analysis]